Alnylam Pharmaceuticals is responsible for the funding and content of this website. The site is intended for Healthcare Professionals in Europe, Middle East and Africa. For disease awareness purposes only.
ThinkPH1 is a trademark of Alnylam Pharmaceuticals, Inc.
©2025 Developed and produced by Alnylam Switzerland GmbH. All rights reserved.
PH1-INTR-00025
January 2025
By accessing the website, you confirm to be a Healthcare Professional from Europe, Middle East, or Africa:
If you are not a Healthcare Professional, please access the LivingwithPH1.eu website here.